CLINICAL_TRIALS
trial_result
· 2017-07-18
Clinical Trial Update: A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 study results for dacomitinib in advanced non-small cell lung cancer have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-18